RE-BVS – Piemonte Repository

Sfoglia per AUTORE
LOCATI L
Collezione AO Ordine Mauriziano

Items : 4

A Data-Driven Approach to Refine Predictions of Differentiated Thyroid Cancer Outcomes: A Prospective Multicenter Study. in The Journal of clinical endocrinology and metabolism / J Clin Endocrinol Metab. 2023 Jul 14;108(8):1921-1928. doi: 10.1210/clinem/dgad075.

2023
AO Ordine Mauriziano
AOU Città della Salute di Torino

Porcelli T; Triggiani V; Castagna MG; Repaci A; Tumino D; Mian C; Crescenzi A; Pezzullo L; Sparano C; Bruno R; Magri F; Monti S; Centanni M; Solaroli E; Castello R; Ceresini G; Rossetto R; D'Amore A; Antonelli A; Puligheddu B; Fugazzola L; Deandrea M; Mele C; Samà MT; Massa M; Crocetti U; Nervo A; Piovesan A; Gagliardi I; et alii...

Corrigendum: Optimizing the use of lenvatinib in combination with pembrolizumab in patients with advanced endometrial carcinoma. in Frontiers in oncology / Front Oncol. 2023 Aug 7;13:1232476. doi: 10.3389/fonc.2023.1232476. eCollection 2023.

2023
AO Ordine Mauriziano

Lorusso D; Danesi R; Locati LD; Masi G; De Giorgi U; Gadducci A; Pignata S; Sabbatini R; Savarese A; Valabrega G; Zamagni C; Colombo N;

Optimizing the use of lenvatinib in combination with pembrolizumab in patients with advanced endometrial carcinoma. in Frontiers in oncology / Front Oncol. 2022 Sep 21;12:979519. doi: 10.3389/fonc.2022.979519. eCollection 2022.

2022
AO Ordine Mauriziano

Lorusso D; Danesi R; Locati LD; Masi G; De Giorgi U; Gadducci A; Pignata S; Sabbatini R; Savarese A; Valabrega G; Zamagni C; Colombo N;

Systematic Review of adverse events reporting in clinical trials leading to approval of targeted therapy and immunotherapy. in Future oncology (London, England) / Future Oncol. 2019 Jul;15(21):2543-2553. doi: 10.2217/fon-2018-0772. Epub 2019 Jun 26.

2019
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Locati LD; Di Giannantonio V; Sbrana A; Musettini G; Sonetto C; Bironzo P; Botta L; Bossi P; Di Maio M; Antonuzzo A;